TP53 and myelodysplastic syndrome: A recent meta-analysis that included 4003 MDS cases and 1278 patients with TP53 gene mutations investigated the impact of the VAF of the TP53 mutation and showed that a high VAF was a severe and independent prognostic factor for survival in MDS cases with TP53 mutation [78].